Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes
Clinical trial NCT03967938 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03967938
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-07
- Primary completion
- 2024-12-31
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.